Reducing Major Adverse Cardiac Events (MACE) with PDE5 Inhibitors

madman

Super Moderator

E. David Crawford, MD, sits down with Robert A. Kloner, MD, Ph.D., and Raymond Rosen, MD, to discuss retrospective evidence of PDE5 inhibitors in preventing major adverse cardiac events (MACE) in men. Crawford, Kloner, and Rosen discuss a retrospective study examining occurrences of MACE in men which demonstrated a significant reduction in MACE in men using PDE5 inhibitors versus those who were not.
 
 

Online statistics

Members online
1
Guests online
45
Total visitors
46

Latest posts

Back
Top